Du är här


CellaVision AB: CellaVision presents the year-end bulletin for 2015 on February 12 at 10:00 CET

The information was submitted to the public on January 22, 2016 at 8:20 CET

CellaVision will publish the year-end bulletin for 2015 on February 12, 2016
at 08:20 CET. The report will be available at www.cellavision.com
In connection with the release of the interim report analysts, investors and
media are hereby invited to a telephone conference and audio webcast at 10:00
CET where Zlatko Rihter, CEO, will present and comment the report.
The presentation will be in English via a conference call or audio webcast:

Phone number for the conference:
SE: +46 8 566 426 92
UK: +44 203 428 14 06
US: +1855 753 22 36
No pre-registration is required. Please dial in 5-10 minutes prior to the
scheduled start time in order to facilitate a timely start.

About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other
body fluids in health care services. The products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge
expertise in image analysis, artificial intelligence and automated
microscopy. Sales are via global partners with support from the mother
company in Lund and by the market support organizations in the USA, Canada,
China and Japan. In 2014 sales were SEK 217 million and sales continue to
increase, with a growth target of at least 15 % per year over an economic
cycle. CellaVision's registered office is in Lund, Sweden. The share is
listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CellaVision AB via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.